The decreasing levels of MDH2 are confirmed in a larger study comprising a total of 493 DMD samples not only in serum but also in plasma (manuscript submitted to Journal of Neuromuscular Diseases). This evidence concerns the gene MDH2 and Duchenne muscular dystrophy.